Skip to main content
. Author manuscript; available in PMC: 2010 May 1.
Published in final edited form as: Regen Med. 2009 Jul;4(4):527–538. doi: 10.2217/rme.09.32

Figure 3. Capillary density assessment in the infarct area.

Figure 3

Immunohistochemical staining of CD31 for endothelial cells in (A) BSA, (B) BM-MSC, (C) BM-MSC in fibrin and (D) fibrin groups. Samples were counterstained with hematoxylin. (E) Quantification of capillary density.

*p = 0.015; p < 0.0001.

BM-MSC: Bone marrow-derived mesenchymal stem cell; BSA: Bovine serum albumin; F: Fibrin.